Back

Cardiol Therapeutics to join B. Riley summit fireside chat on July 16

The Nasdaq- and TSX-listed company said it will appear in Boston as it advances CardiolRx and CRD-38 programs for inflammatory heart disease.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.